They could try doing a rights offering to shareholders rather than going to a loan shark. Toxic financing almost killed this company once. I'm sure it wouldn't be easy and it would take some time to execute, but it seems like it would do less damage. On the downside, there's no way to predict how much money they would raise.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links